<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02786550</url>
  </required_header>
  <id_info>
    <org_study_id>104-8788A3</org_study_id>
    <nct_id>NCT02786550</nct_id>
  </id_info>
  <brief_title>Botulinum Toxin to Improve Lower Blepharoplasty Scar</brief_title>
  <official_title>Botulinum Toxin to Improve Lower Blepharoplasty Scar</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chang Gung Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chang Gung Memorial Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The combination of Botulinum toxin for crow feet (lateral part of orbicularis oculi muscle)
      and lower blaphaloplasty might have reduces the tension on the end of lower blaphaloplasty
      incision whereas the scar is more visible on patient.

      The main aim of this trial is to investigate whether the injection of Botulinum toxin into
      the bilateral orbicularis oculi muscles could improve the appearance of the scar after lower
      blepharoplasty.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The main aim of this double blind randomized trial is to examine whether immediate
      post-operative injection of botulinum toxin into lateral part of bilateral orbicularis oculis
      muscles (the injection technique of crow feet) can improve scar formation for lower
      blepharoplasty patients.

      This is a double blind randomized controlled trial primarily designed to compare the scarring
      after secondary cleft lip repair with immediate post-operative botulinum toxin injection into
      the into bilateral lateral orbicularis oculi muscles in patients with lower blepharoplasty.
      There will be 2 main groups in this study:-

        1. Study group (Group I): Immediately after lower blepharoplasty surgery 3 injections of
           2.5U of botulinum toxin over lateral part of orbicularis oculi muscle.

        2. Control group (Group II): There will be the same amount of normal saline injection after
           lower blepharoplasty.

      Follow-up Assessments Vancouver scar scale measures pigmentation, vascularity, pliability and
      scar height on the postoperative 6 month Follow Up.

      Visual analogue scale They were asked to score the scars on the photographs using a standard
      visual analogue scale graded from 0 (worst possible scar) to 10 (best possible scar).

      Photographic measurement:

      A ruler will be placed just below the surgical scar. Using Photoshop CS5, the scar width can
      be measured.

      Chi-square will be used to analyze the demographic data ( i.e. Gender) The Independent
      T-Student test will be used to analyze the statistical significance between the two groups.

      The dosage of Botox that the investigators use for crowfeet is very tiny. And this is a
      common clinic practice. Systemic insult is unlikely to happen. If an allergic reaction
      occurred it will be treated according to the severity of allergy and Diphenhydramin PO or IV
      form or systemic corticosteroid will be given.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2016</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual analogue scale</measure>
    <time_frame>6 months after surgery</time_frame>
    <description>to score the scars on the photographs using a standard visual analogue scale graded from 0 (worst possible scar) to 10 (best possible scar).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Vancouver scar scale</measure>
    <time_frame>6 months after surgery</time_frame>
    <description>Use vancouver scar scale to access the scar of blepharoplasty</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Photographic measurement</measure>
    <time_frame>6 months after surgery</time_frame>
    <description>A ruler will be placed just below the surgical scar. Using Photoshop CS5, the scar width can be measured</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Other Degenerative Disorders of Eyelid and Periocular Area</condition>
  <arm_group>
    <arm_group_label>Botulinum Toxin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Immediately after lower blepharoplasty surgery 3 injections of 2.5U of botulinum toxin over lateral part of orbicularis oculi muscle.
Intervention: Botulinum toxin injection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Immediately after lower blepharoplasty surgery 3 injections of same amount of normal saline over lateral part of orbicularis oculi muscle.
Intervention: Normal saline injection</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Botulinum Toxin</intervention_name>
    <description>A total of 7.5U per side of botulinum toxin will be injected to the lateral part of obicularis oculis muscle (3 injections of 2.5 U).</description>
    <arm_group_label>Botulinum Toxin</arm_group_label>
    <other_name>Botulinum Toxin Type A</other_name>
    <other_name>Botox</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Normal Saline</intervention_name>
    <description>The same amount (3 cc) of Normal saline will be injected to the lateral part of obicularis oculis muscle</description>
    <arm_group_label>Normal saline</arm_group_label>
    <other_name>Na Cl 0.9%</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Adult â‰¥ 45 years old.

          2. Lower eyelid Rhytidosis and dermatochalasis.

          3. Lower eyelid steatoblepharon and pronounced nasojugal groove

          4. Written informed consent given by patient.

        Exclusion Criteria:

          1. Less than 45 years old

          2. Without written informed consent.

          3. Combined other craniofacial anomalies
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Henry Yau-Li Huang, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Dermatology, Chang Gung Memorial Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chun Shin Chang, M.S.</last_name>
    <phone>+886975365538</phone>
    <email>frankchang@cgmh.org.tw</email>
  </overall_contact>
  <location>
    <facility>
      <name>Chun-Chin Chang</name>
      <address>
        <city>Taoyuan</city>
        <zip>333</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chun Shin Chang, M.D., M.S.</last_name>
      <phone>+88633281200</phone>
      <phone_ext>2430</phone_ext>
      <email>frankchang@cgmh.org.tw</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <reference>
    <citation>Chang CS, Wallace CG, Hsiao YC, Chang CJ, Chen PK. Botulinum toxin to improve results in cleft lip repair: a double-blinded, randomized, vehicle-controlled clinical trial. PLoS One. 2014 Dec 26;9(12):e115690. doi: 10.1371/journal.pone.0115690. eCollection 2014.</citation>
    <PMID>25541942</PMID>
  </reference>
  <reference>
    <citation>Chang CS, Wallace CG, Hsiao YC, Chang CJ, Chen PK. Botulinum toxin to improve results in cleft lip repair. Plast Reconstr Surg. 2014 Sep;134(3):511-6. doi: 10.1097/PRS.0000000000000416.</citation>
    <PMID>25158709</PMID>
  </reference>
  <reference>
    <citation>Zhang DZ, Liu XY, Xiao WL, Xu YX. Botulinum Toxin Type A and the Prevention of Hypertrophic Scars on the Maxillofacial Area and Neck: A Meta-Analysis of Randomized Controlled Trials. PLoS One. 2016 Mar 17;11(3):e0151627. doi: 10.1371/journal.pone.0151627. eCollection 2016.</citation>
    <PMID>26985661</PMID>
  </reference>
  <reference>
    <citation>Lee SJ, Jeong SY, No YA, Park KY, Kim BJ. Combined Treatment with Botulinum Toxin and 595-nm Pulsed Dye Laser for Traumatic Scarring. Ann Dermatol. 2015 Dec;27(6):756-8. doi: 10.5021/ad.2015.27.6.756. Epub 2015 Dec 7.</citation>
    <PMID>26719648</PMID>
  </reference>
  <reference>
    <citation>Prodromidou A, Frountzas M, Vlachos DE, Vlachos GD, Bakoyiannis I, Perrea D, Pergialiotis V. Botulinum toxin for the prevention and healing of wound scars: A systematic review of the literature. Plast Surg (Oakv). 2015 Winter;23(4):260-4. Review.</citation>
    <PMID>26665143</PMID>
  </reference>
  <reference>
    <citation>Zelken J, Yang SY, Chang CS, Chang CJ, Yang JY, Chuang SS, Chen HC, Hsiao YC. Donor Site Aesthetic Enhancement With Preoperative Botulinum Toxin in Forehead Flap Nasal Reconstruction. Ann Plast Surg. 2016 Nov;77(5):535-538. doi: 10.1097/SAP.0000000000000625.</citation>
    <PMID>26418784</PMID>
  </reference>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 26, 2016</study_first_submitted>
  <study_first_submitted_qc>May 31, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 1, 2016</study_first_posted>
  <last_update_submitted>June 22, 2016</last_update_submitted>
  <last_update_submitted_qc>June 22, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 23, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Lower blepharoplasty, Botulinum toxin, Scar</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Eyelid Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Botulinum Toxins</mesh_term>
    <mesh_term>Botulinum Toxins, Type A</mesh_term>
    <mesh_term>onabotulinumtoxinA</mesh_term>
    <mesh_term>abobotulinumtoxinA</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

